IA

FLEXION THERAPEUTICS GRANTED FAST TRACK STATUS BY THE FDA FOR FX006 FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE

BURLINGTON, MASS., September 01, 2015 – Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced that the U.S. Food and Drug Administration (FDA)…